BOLD. TANGY.
INTENTIONAL.
DESIGNED FOR YOUR HEART <3
We don’t believe heart health comes from hacks or extremes. It comes from the small choices you repeat every day. That’s why TELVARI is formulated with carefully selected ingredients grounded in nutrition science.
THE 3 PILLARS
Because your heart health matters to us.
Potassium
Potassium helps regulate blood pressure by balancing the effects of sodium in your body. Most Americans consume significantly less than the recommended daily amount. The US Dietary Guidelines specifically flag it as one of the most underconsumed nutrients in the American diet. This is why we made Telvari to get you 20% (DV) of the way there.
Anthocyanins
Anthocyanins are the natural compounds that give hibiscus its deep red color. Studies have looked at how hibiscus consumption relates to blood pressure, with research suggesting anthocyanins may help blood vessels relax and regulate blood flow more effectively.
Taurine
Taurine is an amino acid your body naturally produces and concentrates in heart and muscle tissue. It plays a role in how your heart muscle contracts and relaxes. Populations with naturally high taurine intake through diet have been observed to have lower rates of cardiovascular disease.
THE NO LIST
TELVARI is designed around absence as much as inclusion. We intentionally avoid ingredients that don’t align with daily use.
NO added sugars to spike your blood glucose
NO artificial sweeteners or sugar alcohols
NO stimulants that create dependencies
NO megadosed vitamins or unnecessary fortification
Caffeine Free. Sugar Free. Sodium Free. Gluten Free. Fat Free. Dairy Free. Vegan.
SCIENCE
We use ingredients with human evidence of efficacy. Not weak mechanistic papers or rat studies.
A randomized, double-blind, placebo-controlled clinical trial found hibiscus tea consumed daily for six weeks lowered systolic blood pressure by 7.2 mmHg compared to placebo in pre- and mildly hypertensive adults not on medication.
Read the paper
A meta-analysis of RCTs found hibiscus reduced systolic blood pressure by 7.1 mmHg versus placebo and produced blood pressure reductions comparable to pharmaceutical antihypertensive medications, while also significantly lowering LDL cholesterol.
Read the paper
A meta-analysis of seven RCTs found regular hibiscus consumption significantly reduced systolic blood pressure, diastolic blood pressure, and fasting plasma glucose, supporting its role in reducing multiple cardiovascular disease risk factors simultaneously.
Read the paper
A randomized, double-blind, placebo-controlled trial in prehypertensive adults showed taurine supplementation significantly lowered both systolic and diastolic blood pressure and improved vascular function, including endothelial dilation and arterial stiffness markers.
Read the paper
A 2024 meta-analysis of RCTs found taurine supplementation significantly reduced heart rate, systolic blood pressure, diastolic blood pressure, and improved left ventricular ejection fraction, with no meaningful adverse effects across studies.
Read the paper
A 2025 meta-analysis of 34 RCTs found taurine supplementation significantly reduced fasting blood glucose, HbA1c, triglycerides, total cholesterol, LDL, systolic blood pressure, diastolic blood pressure, CRP, and inflammatory markers in adults.
Read the paper
A dose-response meta-analysis of 10 RCTs found that potassium supplementation reduced systolic blood pressure by up to 5.3 mmHg and diastolic blood pressure by 3.6 mmHg in people with hypertension, with effects increasing at higher sodium intakes.
Read the paper
A meta-analysis of 15 RCTs in non-medicated adults showed potassium supplementation reduced systolic blood pressure by 4.7 mmHg overall and by 6.8 mmHg specifically in those with hypertension, with greater benefit linked to reduced sodium-to-potassium ratio.
Read the paper
A meta-analysis of 18 long-term RCTs confirmed potassium supplementation lowers systolic blood pressure by 4.48 mmHg and diastolic by 2.96 mmHg in people with hypertension, with strongest effects in high sodium consumers not on drug treatment.
Read the paper
